(Q64857382)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

1 reference

10.1136/BMJ.1.6118.954

https://api.crossref.org/works/10.1136/BMJ.1.6118.954

27 August 2023

P. Bédard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A638546

17 July 2022

J. D. Parkes

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A638546

17 July 2022

C. D. Marsden

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A638546

17 July 2022

language of work or name

English

0 references

publication date

1 April 1978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

15 April 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=638546

full work available at URL

17 July 2022

https://europepmc.org/articles/PMC1603806

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A638546

https://europepmc.org/articles/PMC1603806?pdf=render

17 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A638546

https://syndication.highwire.org/content/doi/10.1136/bmj.1.6118.954

17 July 2022

1 reference

Crossref

DOI

10.1136/BMJ.1.6118.954

https://api.crossref.org/works/10.1136/BMJ.1.6118.954

27 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

6118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

954-956

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

Neuroleptic antagonism of dyskinetic phenomena

11 September 2019

cites work

1 reference

12 December 2020

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

1 reference

12 December 2020

Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias

1 reference

12 December 2020

Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.1.6118.954

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:638546%20AND%20SRC:MED&resulttype=core&format=json